When operations become safer, attention inevitably shifts from mortality to morbidity. Unfortunately, morbidity is more difficult to measure than death, but it is arguably of greater interest to the patient and to those from public or private institutions that have the responsibility for balancing a health care budget. Studies that focus on morbidity are currently few, and specific risk models are being developed. It is already evident that risk factors associated with hospital death are qualitatively different from risk factors associated with prolonged hospital stay. The study of morbidity after coronary artery surgery is important to surgeons and physicians, to assess quality of care and the impact of new treatments and procedures. Curr Opin Cardiol 2000, 15:400-405 Abbreviations CABG coronary artery bypass grafting CEA carotid endarterectomy IMA internal mammary artery LVEF left ventricular ejection fraction MIDCAB minimally invasive direct coronary artery bypass
Coronary artery surgery continues to change, with a greater emphasis on arterial grafting, refinements in cardioplegia, increased use of measures to prevent atherosclerotic emboli, and the introduction of minimally invasive surgery with or without the use of cardiopulmonary bypass. Furthermore, the indications for coronary artery surgery are changing. Angioplasty with stent deployment is being used for flow-limiting lesions in all major arteries. Emergency coronary artery surgery in the setting of acute myocardial infarction is being replaced by thrombolysis and interventional cardiology techniques. Generally, catheter-based techniques are being used more widely for multivessel coronary artery disease. Coronary artery surgery remains the procedure of choice for patients with multivessel disease and impaired left ventricular function, for those with left main stem disease, and for those with diffuse coronary disease, particularly diabetic patients. Against this background, analysis of patient outcome is of interest to many people. There are at least four important outcomes to consider: mortality, morbidity, resource utilization, and patient satisfaction. Those patient characteristics that constitute important risk factors all depend to some extent on the outcome of interest. Most studies to date have focused on mortality as an outcome. In 1989, Parsonnet et al. [1] described a model of risk stratification for patients undergoing adult cardiac surgery. Since that time, several groups have reported refinement in the estimation of the risk of coronary artery surgery. Edwards et al. [2] developed risk models for isolated coronary artery bypass surgery based on the Society of Thoracic Surgeons National Cardiac Surgical Database. Data from more than 300,000 patients undergoing surgery from 1990 to 1994 were used in the development of risk models of operative mortality. Five validation techniques were used to determine the reliability of the risk models, and all the models were found to predict operative mortality with accuracy in the population studied. Edwards et al. [2] found that significant risk factors with an odds ratio of 1.5 or greater were reoperation, coronary surgery, preoperative or intraoperative balloon pump, dialysis-dependent renal failure, cerebrovascular accident, use of immunosuppressive drugs, cardiogenic shock, resuscitation, and emergency operation. In 1992, Higgins [3] , from the Cleveland Clinic, reported a model to predict morbidity and mortality in coronary artery patients based on preoperative risk factors. This model took into account events in the operating theater, physiologic measurements in the intensive care unit, and preoperative factors. The model was based on data collected from 2793 patients and validated during a subsequent period in 2125 patients. The mortality rate in the population was 3.1% and the morbidity rate was 10.4%. The model assigned point values from 1 to 7 on the basis of the logistic regression coefficient. A score of less than 5 at the time of admission to the intensive care unit predicted a risk of less than 1% for mortality and less than 5% for morbidity. Factors with a weight of 3 or more included previous surgery or angioplasty for peripheral vascular disease, age 70 years or greater, a preoperative serum creatinine level of 1.9 mg/dL and a preoperative albumin level of less than 3.5 mg/dL, cardiopulmonary bypass time in excess of 160 minutes, use of intra-aortic balloon pump after cardiopulmonary bypass, cardiac index of less than 2.1 L/minute/m 2 , central venous pressure of 17 mm Hg, and an arterial bicarbonate of less than 1.0.
More recently, Sergeant et al. [4] reported the effect of patient procedural and surgical variables on early and late survival after isolated coronary artery surgery. This group looked at a consecutive series of 9600 patients who underwent coronary artery surgery in one institution between 1971 and 1992. Follow-up information was complete in an exceptional 99.9%. The authors performed a multivariate time-related analysis, studying the influences and interdependency of patient variables, including variations and details of procedure. The unadjusted survival rates at 1, 10, and 20 years were 97%, 81%, and 50%, respectively. Patient variables that influenced late survival were left ventricular function and cardiac and noncardiac morbidity. The authors were particularly interested in the significance of arterial grafting. They found that late survival was modestly improved with the use of an arterial graft to a major vessel, preferably to the left anterior descending artery, except for patients with a limited life expectancy. Differences in time-related survival with or without an arterial graft were not importantly affected by left ventricular ejection fraction (LVEF).
Studies that focus on morbidity as opposed to mortality are also required but should include an assessment of length of stay as a measure of resource utilization and quality of life as an indicator of patient satisfaction. Such outcome measures are particularly important in deciding how to use limited health budgets wisely. It has been estimated that as much as 40% of the yearly hospital costs for coronary artery surgery are consumed by 10 to 15% of the patients who have serious complications after operation [5] . The clinical variables associated with morbidity after operation may differ from those associated with mortality. There is evidence to suggest that risk factors associated with an in-hospital death reflect coexisting disease-specific variables, whereas factors associated with resource utilization include comorbid illness [6] . For example, a risk of death after coronary artery surgery is associated with disease-specific factors such as recent myocardial infarction and low ejection fraction, whereas the risk factors for increased length of stay and use of resources include comorbidity such as peripheral vascular disease, chronic obstructive airways disease, and renal failure. In this way, comorbid conditions become important predictors of hospital costs, because they often predict prolonged hospital stay.
Engelman et al. [7] from Boston conducted a retrospective study to see whether extremes of body mass index (high or low) increased the morbidity and mortality of cardiac operations. They found that low body mass index (<20) and low serum albumin (2.5 g/dL) each independently predicted increased morbidity and mortality after adult cardiac surgery. Also, a body mass index greater than 30 was associated with an increased incidence of infection of the sternal wound and leg wound.
Diabetes in coronary artery disease
In a post-hoc subgroup analysis of the results of the Bypass Angioplasty Revascularization Investigation study [8, 9] , patients with diabetes who were randomly assigned to undergo angioplasty did significantly worse than those who were randomly assigned to receive a coronary artery bypass graft. The excess mortality associated with angioplasty is largely but not completely due to an adverse outcome after myocardial infarction. If these findings are correct, it is uncertain whether the worse outcomes in patients with diabetes were due to an intrinsic aspect of the diabetic state or to poor glycemic control. The high incidence of coronary heart disease in patients with diabetes and the high fatality rate support the need for additional clinical trials of revascularization in diabetic patients with coronary artery disease. Although diabetic patients receive satisfactory symptomatic relief of angina, they are well known to suffer increased perioperative wound complications and a greater incidence of long-term cardiac morbidity. The management of diabetic patients should be associated with aggressive management of risk factors for cardiovascular disease and glycemia. Such management implies the use of aspirin, beta blockers, and angiotensin-converting enzyme inhibitors together with careful control of glycemia.
Coronary artery surgery in patients who have renal disease
The patient with impaired renal function is at increased risk, with an odds ratio of nearly 3.9 for death after coronary surgery [10] . However, these patients can undergo operation with appropriate case selection and careful preparation that optimizes the kidneys before and during the operation. Hypotension must be rigorously avoided and agents such as dopamine and diuretics may play a protective role. Drugs cleared by the kidneys must be used in adjusted doses and frequencies, or an alternative must be sought. Dialysis should be considered early for any patient developing renal impairment postoperatively and used aggressively but gently to prevent further multisystem organ damage. The use of chronic arteriovenous hemofiltration is an effective tool for this purpose. Chertow et al. [11] have shown that the risk of acute renal failure after cardiac surgery can be accurately quantified on the basis of readily available preoperative data. They identified 10 clinical variables that allowed separation of patients into low-, medium-, and high-risk groups. This enables the surgeon to target high-risk subgroups for intervention aimed at reducing the risk and enumerating the consequences of this serious complication. It should be noted that in their prospective cohort study of 3795 patients operated on between April and December 1994 in a group of 43 Veterans Administration Hospitals, the overall risk of acute renal failure requiring dialysis was 1.1%, and the 30-day mortality rate in patients who did develop renal failure was 63.7%, compared with 4.3% in patients without acute renal failure. These figures underline the seriousness of postoperative renal failure.
Effect of left ventricular function on outcome after coronary artery surgery
Many studies have identified incremental risk factors for death after coronary artery. Only a few studies have focussed on clinical predictors of operative mortality in patients with left ventricular dysfunction and have reported inconsistent results. In one study of 466 patients with LVEF less than 0.4 [12], operative mortality was related to ejection fraction, being increased in patients with a lower ejection fraction. In contrast, in an analysis of 224 patients from the Netherlands with LVEF less than 0.3, mortality was not influenced by a decreasing ejection fraction but instead by clinical markers of heart failure such as New York Heart Association class and left ventricular enddiastolic pressure [13] . Another study from the United States [14] identified age and renal disease as predictors of operative mortality but did not note an increased mortality rate in patients with heart failure. Analysis of the Coronary Artery Bypass Grafting Patch Trial Database [15••] demonstrated that despite traditional concerns about operative risks in patients with ventricular dysfunction, patients without heart failure symptoms may undergo coronary artery bypass grafting (CABG) with low mortality despite low ejection fraction, high left ventricular end-diastolic pressure, advanced age, or comorbid conditions such as diabetes, hypertension or chronic obstructive pulmonary disease. Furthermore, although the presence of clinical heart failure symptoms confers a greater than twofold increase in the risk of death, patients with low ejection fraction and advanced heart failure may still expect a perioperative mortality rate of less than 10%. This increased mortality risk may not be prohibitively high in patients who stand to benefit significantly from surgical revascularization, but it does serve to emphasize the importance of proper selection of patients with surgically correctable ischemia. The length of hospital stay is significantly increased by advanced age, a history of stroke, and the presence and severity of clinical heart failure.
Beating heart surgery
The avoidance of cardiopulmonary bypass has been a driving force behind the renewed interest in minimally invasive coronary artery surgery, especially of the off-pump coronary artery bypass variety performed via a midline sternotomy. Numerous studies have shown a highly significant correlation between cardiopulmonary bypass category and undesirable postoperative events. The inflammatory reaction initiated by cardiopulmonary bypass has always been seen as an important disadvantage [16] . In a prospective randomized study, Ascione et al. [17•] compared beating heart versus arrested heart for coronary revascularization. Myocardial injury as assessed by troponin I release into the peripheral circulation was reduced in the beating heart group compared with on-pump, warm blood cardioplegic arrest. These patients were a low-risk group, the majority having an LVEF greater than 50% and none less than 30%. The number of grafts per patient was low, at 2.1 off-pump and 2.3 onpump. No postoperative coronary arteriograms were obtained. Nevertheless, this is one of the very few randomized studies available.
Further information regarding morbidity comes from a retrospective study by Magovern et al. [18] of 115 patients undergoing elective LIMA to left anterior descending artery bypass via either minimally invasive direct coronary artery bypass (MIDCAB) (60 patients) or coronary artery surgery on pump with cardioplegic arrest (35 patients) between 1995 and 1996. There were no deaths in either group. Patients undergoing the MIDCAB procedure showed reduced morbidity and in-hospital costs, which were most evident in a high-risk group. The MIDCAB patients had a lower incidence of transfusion (10 of 60 (17%) compared with 22 of 55 (40%); P = 0.02), and a shorter postoperative ventilation period (2.1 ± 4.2 hours compared with 12.6 ± 9 hours; P = 0.0001). The median length of stay after operation was 4 days for the MIDCAB group and 7 days for the on-pump group. This is encouraging, but it should be noted that at 6 months' follow-up, five of the MIDCAB patients (8%) had evidence of recurrent ischemia involving five of the left anterior descending artery grafts as a result of anastomotic stricture. In a nonrandomized study using historical controls, 300 offpump CABG patients were compared [19] with 1870 patients operated on with cardiopulmonary bypass. These operations were performed in one institution by a single surgeon. Seventy percent of the patients had three or four coronary bypass grafts and were well matched for age, gender, and preoperative risk factors. The ischemic time and the need for transfusion postoperatively were significantly less in the beating heart group. Similarly, there was significantly less use of the intra-aortic balloon pump as well as a lower rise in serum creatinine in the beating heart group compared with the cardiopulmonary bypass group. There was no difference in the incidence of inotropic support after the operation, wound infection, reintervention for bleeding, and incidence of stroke in the two groups.
The major morbidity of coronary artery surgery employing cardiopulmonary bypass is neuropsychometric damage. It is widely hoped that off-pump coronary artery surgery may lead to a significant reduction of this problem. Cerebral embolization is currently thought to be the most common cause of postoperative brain damage. Murkin et al. [20] has suggested that off-pump coronary surgery should reduce cerebral injury by reducing the cerebral embolic load. They reported a reduction in the incidence of cognitive dysfunction 3 months after operation, from 50% in patients undergoing on-pump surgery to 5% in patients undergoing off-pump surgery. The study was nonrandomized, and the patients in the off-pump group received fewer grafts (1.1 versus 3.2) than in the on-pump group. By contrast, Taggart et al. [21] compared cognitive outcome in patients undergoing coronary artery surgery with and without cardiopulmonary bypass and reported no significant difference between the groups. This was also a nonrandomized study and the cardiopulmonary bypass times were short, with a median of 68 minutes. Anderson et al. [22] , in a nonrandomized study, reported that the S100 protein measured in peripheral blood was 10-fold lower in patients undergoing off-pump coronary surgery compared with on-pump surgery. No correlation was made between levels of S100 and neuropsychometric status in the postoperative period. Unfortunately, S100 may not be so specific to central nervous system injury in this setting, as was previously believed, and therefore may not be a reliable surrogate for neuropsychometric injury. In a more recent publication by the same group [23•], the suggestion is made that S100 levels recorded after cardiopulmonary bypass with cardiotomy suction may be largely of extracerebral origin, from adipocytes released at the time of sternotomy. They found that S100 beta levels early postoperatively after cardiopulmonary bypass with a cell-saver device as opposed to cardiotomy suction, was very similar to levels recorded early after off-pump coronary artery operations. S100 is a family of proteins, two of which originate from astroglial and Schwann cells in the brain. Currently used assays detect any S100 protein that contains at least one beta subunit, for example, adipocytes. The authors caution against the bland assumption that S100 beta is a serum marker of brain damage after cardiopulmonary bypass. Clearly, we need more knowledge to help us understand how to interpret elevated S100 beta values in patients undergoing coronary artery surgery.
Despite the enormous enthusiasm for beating heart surgery, especially in North America, we await the evidence that it represents a major step forward in terms of a reduction in morbidity.
Role of total arterial revascularization
The development of total arterial revascularization has been slow, with isolated pockets of enthusiasm. One of the reasons for this has been a widely held belief that bilateral internal mammary artery (IMA) use is associated with an increased incidence of sternal wound infection. An interesting study from Paris [24] retrospectively examined 207 consecutive diabetic patients undergoing coronary artery surgery. In 74 patients, bilateral IMA was used and in the remaining 133 unilateral IMA with long saphenous vein grafts served as the conduit. The IMAs were harvested by skeletonization without the use of diathermy and strict glycemic control was pursued. There was no significant difference in the morbidity rate between the two groups except for greater blood loss in the bilateral IMA group. No deaths were observed in the bilateral IMA group, whereas seven patients died in the unilateral IMA group (P < 0.05). Deep sternal wound infection was observed in two patients in the unilateral group (1.5%) and in none of the bilateral group (NS). The authors suggest that the low rate of sternal infections in the bilateral IMA group may be related to skeletonization. Clearly, a larger randomized controlled trial will be required to confirm or refute this suggestion.
Evidence from Royse et al. [25] from Melbourne, Australia, suggests that total arterial revascularization using both IMAs, radial arteries, and complex arterial reconstructions are associated with a reduced in-hospital mortality. They found in a retrospective study that the in-hospital mortality rate for total arterial revascularization was 0.7 versus 2.9% when veins grafts were used. As in other studies, they found that preoperative renal failure, intra-aortic balloon pump use, and redo coronary surgery were predictive of a greater in-hospital mortality.
Concomitant carotid and coronary artery disease
The common occurrence of carotid artery disease in patients in need of coronary bypass surgery is well established, with an incidence that varies from 11 to 20% [26] . The management of patients with atherosclerosis of the coronary and cerebral circulations remains controversial and differs widely in different institutions. Johnson et al. from Sweden [27] have examined the problem of cerebral perfusion on cardiopulmonary bypass in the presence of carotid artery disease. If the perfusion pressure is maintained above 50 mm Hg and alpha-stat regulation is used, cerebral blood flow is maintained beyond carotid stenoses of 80% or more. It is also known that the risk of diffuse cerebral injury is not increased in patients with asymptomatic carotid disease [28] . If reduced perfusion were the inevitable consequence of a fixed carotid obstruction, we would expect a much more predictable relationship between the severity of carotid stenosis, diffuse cerebral injury, and stroke. The evidence suggests that a minority of strokes that complicate cardiac surgery are directly attributable to carotid disease [29] .
Nevertheless, there is a group of patients who require operations on both their carotid and coronary arteries. Although some reports suggest that the staged procedure with the carotid endarterectomy (CEA) performed first decreases the risk of cerebral infarct with cardiopulmonary bypass, other investigators have demonstrated that simultaneous CEA and CABG can be performed with no increase in either morbidity or mortality. To explain this controversy is difficult because of the lack of any controlled randomized study that demonstrates the safety of combined versus staged procedures. There are also numerous other variables that can affect outcome. In some institutions, the CEA and CABG are performed by two different surgeons and in some by the same surgeon.
In the series by Brener et al. [30] , the rate of neurologic complications was higher than anticipated in the combined CEA/CABG group, especially in the presence of a contralateral internal carotid artery occlusion. In patients undergoing only coronary revascularization with severe carotid artery stenosis, the authors found a 6% incidence of stroke post-CABG and 15% if the contralateral carotid was also occluded. As the study progressed, they began to omit the CEA in those patients who were asymptomatic as far as their carotid disease was concerned and found that there was no increase in the incidence of neurologic events. The authors also favored CEA before CABG in those patients with symptomatic carotid artery disease in need of CABG [31] . The most important predictors of stroke, according to this study, are previous myocardial infarc-tion, left main coronary artery stenosis, and a greater than 80% occlusion of the internal carotid artery. It has been shown that myocardial infarction after CEA in patients with severe symptomatic coronary artery disease can be as high as 18%. A number of authors have addressed the issue of staged CEA/CABG with results showing a risk of stroke from 0 to 6.7% and a risk of death from 0 to 33%. Cambria et al. [32] concluded that, optimally, carotid bifurcation disease that warranted surgery should be corrected first if the coronary artery disease is clinically stable. Coyle et al. [33] reported the experience at Emory University over a 10year period with simultaneous CEA/CABG and came to a similar conclusion that only very high risk patients with both symptomatic and coronary artery disease should undergo a simultaneous procedure. Their experience suggested that delaying CABG by several days would reduce the overall rate of stroke and mortality.
A pragmatic decision must be based on the existing studies, although a randomized study is urgently needed. It is likely that CEA places an ischemic insult on the brain, as does cardiopulmonary bypass. When both are combined in the same setting, the effect may not merely be additive but compounded, thus increasing the observed stroke rate in a simultaneous CEA/CABG group. Therefore, it seems a reasonable strategy that staging should be applied with CEA first followed by CABG on a subsequent day during the same hospital admission.
Conclusion
The study of morbidity after coronary artery surgery is of increasing importance not only to the patient but also to those who pay for health care from public health budgets or private insurance. The indications for operation in individual cases need frequent re-evaluation as older and sicker patients present for surgery. Total arterial revascularization in selected patients may, in addition to improving long-term outcome, also reduce early morbidity. It seems likely that off-pump coronary artery surgery will make a significant contribution to reducing morbidity, but the magnitude and nature of that contribution remain uncertain.
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